Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-05-15
1993-05-18
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548200, C07D27704, A61K 31425
Patent
active
052121917
ABSTRACT:
Heterocyclic compounds of the general formula: ##STR1## wherein, Z represents sulfur atom, R represents a general formula:
REFERENCES:
patent: 4226775 (1980-10-01), McEvoy et al.
patent: 4857537 (1989-08-01), Toda
patent: 4880827 (1989-11-01), Tamoto et al.
patent: 4912128 (1990-03-01), Henning et al.
patent: 4956380 (1990-09-01), Toda et al.
patent: 4983623 (1991-01-01), Henning et al.
patent: 5051444 (1991-09-01), Tamoto et al.
Charton, Methods in Enzymology pp. 323, 330-333 (1989).
Sinkula, Annual Reports, Medicinal Chemistry. vol. 10 pp. 306, 310, 314 (1975).
Protein Nucleic Acid & Enzyme 26(6), pp. 513-523; (1980).
Nippon Nogeikagaku Kaishi 58(11), pp. 1147-1153; (1983).
Journal of Neurochemistry, 41(1), pp. 69-75 (1983).
Journal of Neurochemistry, 42(1), pp. 237-241 (1984).
Science, 211(4482), pp. 601-603 (1981).
J. Biochem, 94, pp. 1179-1190 (1983).
Ohno Hiroyuki
Ohuchida Shuichi
Toda Masaaki
Gerstl Robert
Ono Pharmaceutical Co. Ltd.
LandOfFree
Heterocyclic compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-804720